EDGAR Filing Documents for 0001193125-21-062224

Form 8-K - Current report:

SEC Accession No. 0001193125-21-062224

Filing Date

2021-03-01

Accepted

2021-03-01 07:01:20

Documents

Period of Report

2021-02-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d136544d8k.htm	8-K	23001
2	EX-10.1	d136544dex101.htm	EX-10.1	203415
3	EX-10.2	d136544dex102.htm	EX-10.2	123871
4	EX-99.1	d136544dex991.htm	EX-99.1	29678
5	EX-99.2	d136544dex992.htm	EX-99.2	52737
6	GRAPHIC	g136544ex99_2s10g1.jpg	GRAPHIC	221279
7	GRAPHIC	g136544ex99_2s11g1.jpg	GRAPHIC	306190
8	GRAPHIC	g136544ex99_2s12g1.jpg	GRAPHIC	399602
9	GRAPHIC	g136544ex99_2s13g1.jpg	GRAPHIC	510908
10	GRAPHIC	g136544ex99_2s14g1.jpg	GRAPHIC	299300
11	GRAPHIC	g136544ex99_2s15g1.jpg	GRAPHIC	328733
12	GRAPHIC	g136544ex99_2s16g1.jpg	GRAPHIC	363403
13	GRAPHIC	g136544ex99_2s17g1.jpg	GRAPHIC	322622
14	GRAPHIC	g136544ex99_2s18g1.jpg	GRAPHIC	367144
15	GRAPHIC	g136544ex99_2s19g1.jpg	GRAPHIC	511678
16	GRAPHIC	g136544ex99_2s1g1.jpg	GRAPHIC	306036
17	GRAPHIC	g136544ex99_2s20g1.jpg	GRAPHIC	363508
18	GRAPHIC	g136544ex99_2s21g1.jpg	GRAPHIC	514522
19	GRAPHIC	g136544ex99_2s22g1.jpg	GRAPHIC	510323
20	GRAPHIC	g136544ex99_2s23g1.jpg	GRAPHIC	512566
21	GRAPHIC	g136544ex99_2s24g1.jpg	GRAPHIC	529503
22	GRAPHIC	g136544ex99_2s25g1.jpg	GRAPHIC	378058
23	GRAPHIC	g136544ex99_2s26g1.jpg	GRAPHIC	340727
24	GRAPHIC	g136544ex99_2s27g1.jpg	GRAPHIC	186140
25	GRAPHIC	g136544ex99_2s28g1.jpg	GRAPHIC	285755
26	GRAPHIC	g136544ex99_2s29g1.jpg	GRAPHIC	282739
27	GRAPHIC	g136544ex99_2s2g1.jpg	GRAPHIC	889591
28	GRAPHIC	g136544ex99_2s30g1.jpg	GRAPHIC	162456
29	GRAPHIC	g136544ex99_2s31g1.jpg	GRAPHIC	286751
30	GRAPHIC	g136544ex99_2s32g1.jpg	GRAPHIC	259035
31	GRAPHIC	g136544ex99_2s33g1.jpg	GRAPHIC	506831
32	GRAPHIC	g136544ex99_2s34g1.jpg	GRAPHIC	214981
33	GRAPHIC	g136544ex99_2s35g1.jpg	GRAPHIC	582802
34	GRAPHIC	g136544ex99_2s36g1.jpg	GRAPHIC	435078
35	GRAPHIC	g136544ex99_2s37g1.jpg	GRAPHIC	293120
36	GRAPHIC	g136544ex99_2s38g1.jpg	GRAPHIC	308200
37	GRAPHIC	g136544ex99_2s39g1.jpg	GRAPHIC	288273
38	GRAPHIC	g136544ex99_2s3g1.jpg	GRAPHIC	526910
39	GRAPHIC	g136544ex99_2s40g1.jpg	GRAPHIC	268686
40	GRAPHIC	g136544ex99_2s41g1.jpg	GRAPHIC	325296
41	GRAPHIC	g136544ex99_2s42g1.jpg	GRAPHIC	394103
42	GRAPHIC	g136544ex99_2s4g1.jpg	GRAPHIC	319473
43	GRAPHIC	g136544ex99_2s5g1.jpg	GRAPHIC	395544
44	GRAPHIC	g136544ex99_2s6g1.jpg	GRAPHIC	329170
45	GRAPHIC	g136544ex99_2s7g1.jpg	GRAPHIC	407624
46	GRAPHIC	g136544ex99_2s8g1.jpg	GRAPHIC	320812
47	GRAPHIC	g136544ex99_2s9g1.jpg	GRAPHIC	260120
48	GRAPHIC	g136544g37u19.jpg	GRAPHIC	5455
	Complete submission text file	0001193125-21-062224.txt		21954520

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080

Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809

Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)